Contents
[hide]
[show]

Spondyloepimetaphyseal dysplasia Strudwick type is a rare genetic condition that affects the growth and development of bones, cartilage, and other connective tissues. The condition is associated with a short stature and abnormalities in the vertebrae and long bones. Individuals with this condition typically have early-onset arthritis and may experience other skeletal abnormalities as well.

Learning about the causes, symptoms, and treatment options for spondyloepimetaphyseal dysplasia Strudwick type can be challenging due to its rarity. However, there are resources available to help individuals and their families navigate this condition. PubMed and OMIM are valuable scientific databases that contain articles and references on genetic diseases. The Strudwick Syndrome Advocacy Support Center is a nonprofit organization that provides support and information for individuals and families affected by this condition.

Genetic testing can be helpful in diagnosing spondyloepimetaphyseal dysplasia Strudwick type. Testing can identify mutations in specific genes that are associated with the condition. Additional testing, such as X-rays and MRI scans, may be necessary to assess the severity of the skeletal abnormalities. With proper diagnosis and management, individuals with spondyloepimetaphyseal dysplasia Strudwick type can lead fulfilling lives.

Frequency

The frequency of Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-ST) is unknown. It is considered a rare condition.

SEMD-ST affects the growth of bones and cartilage, and it is caused by mutations in the COL2A1 gene. According to the information available on PubMed, there have been several scientific articles published on this condition. However, the exact frequency of SEMD-ST is not well documented.

Learning more about the inheritance pattern of SEMD-ST can provide additional information on the frequency of this condition. According to OMIM (Online Mendelian Inheritance in Man), SEMD-ST has an autosomal dominant inheritance pattern. This means that individuals with a mutation in one copy of the COL2A1 gene can develop the condition. However, it is important to note that SEMD-ST can also occur sporadically, without a family history of the condition.

In studies, the artificial intelligence (AI) technology used in some online health services for preliminary screening before connecting patients with a doctor actually outperformed real physicians in terms of reaching an accurate diagnosis, CNN AI technology correctly diagnosed conditions in 81% of patients, compared to a 72% average for accurate diagnoses among real physicians over a five-year period.

Genetic testing can be used to confirm a diagnosis of SEMD-ST. This testing can detect mutations in the COL2A1 gene, providing further support for the diagnosis. Genetic testing can also help differentiate SEMD-ST from other genetic diseases that may present with similar symptoms.

Additional resources, such as advocacy organizations and support groups, can provide more information on the frequency of SEMD-ST. These resources can also connect individuals and families affected by this condition to additional support and information.

References:

  • Strudwick Syndrome – Genetics Home Reference: https://ghr.nlm.nih.gov/condition/strudwick-syndrome#frequency
  • Spondyloepimetaphyseal dysplasia, Strudwick type – OMIM: https://omim.org/entry/184250
  • Catalog of Genes and Diseases – Center for Biological References: http://www.cbrc.kaust.edu.sa/dspd/SEMD-ST
  • Spondyloepimetaphyseal Dysplasia Strudwick Type – National Organization for Rare Disorders: https://rarediseases.org/rare-diseases/spondyloepimetaphyseal-dysplasia-strudwick-type/

Causes

Spondyloepimetaphyseal dysplasia Strudwick type is a rare genetic condition that affects the growth and development of bones, particularly in the vertebrae and long bones of the arms and legs. It is also known as Strudwick syndrome or SEMD Strudwick type.

The exact cause of Spondyloepimetaphyseal dysplasia Strudwick type is not yet fully understood. However, it is known to be associated with mutations in the COL2A1 gene, which provides instructions for making a protein called type II collagen. This protein is important for the formation and maintenance of cartilage, which is a flexible connective tissue that plays a critical role in bone development.

Most cases of Spondyloepimetaphyseal dysplasia Strudwick type are inherited in an autosomal dominant pattern, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. However, in some rare cases, the condition can also occur sporadically, with no family history.

To confirm a diagnosis of Spondyloepimetaphyseal dysplasia Strudwick type, genetic testing can be performed to look for mutations in the COL2A1 gene. Additional testing, such as imaging studies and evaluation of skeletal development, may also be done to support the diagnosis. The condition can sometimes be diagnosed prenatally through fetal ultrasound.

For more information about Spondyloepimetaphyseal dysplasia Strudwick type, you can visit the websites of scientific resources like OMIM or PubMed, as well as advocacy and support organizations like the Spondyloepimetaphyseal Dysplasia Support and Research Center.

See also  PPP2R5D-related intellectual disability

Learn more about the gene associated with Spondyloepimetaphyseal dysplasia Strudwick type

Spondyloepimetaphyseal dysplasia Strudwick type is a rare genetic condition that affects the growth and development of the bones and connective tissues, causing short stature and skeletal abnormalities. This condition is caused by mutations in the COL2A1 gene.

The COL2A1 gene provides instructions for making a protein called type II collagen, which is a major component of cartilage and other connective tissues. Mutations in this gene can lead to the production of an abnormal version of type II collagen, which disrupts the normal development and function of cartilage in the vertebrae and other bones. This can result in the characteristic features of Spondyloepimetaphyseal dysplasia Strudwick type, including short stature, abnormal curvature of the spine, and early-onset arthritis.

To learn more about the COL2A1 gene and its association with Spondyloepimetaphyseal dysplasia Strudwick type, you can explore scientific articles and resources. PubMed, a comprehensive database of scientific research articles, is a good starting point. Searching for keywords such as “COL2A1 gene” or “Spondyloepimetaphyseal dysplasia Strudwick type” can provide you with additional information and references for genetic testing, inheritance patterns, and other related topics.

The Online Mendelian Inheritance in Man (OMIM) database is another valuable resource for learning about genetic conditions. The entry for Spondyloepimetaphyseal dysplasia Strudwick type in OMIM provides information on the frequency of the condition, associated genes, and additional references for further reading.

In addition to scientific articles and databases, you can also consult patient support organizations and genetic counseling centers for more information on Spondyloepimetaphyseal dysplasia Strudwick type. These resources can provide valuable insights into the condition, connect you with other individuals and families affected by the syndrome, and offer support and guidance for managing the condition.

Inheritance

The Spondyloepimetaphyseal dysplasia Strudwick type is a rare genetic syndrome characterized by skeletal dysplasia, early onset arthritis, and short stature.

The condition is inherited in an autosomal dominant manner, which means that a person with one affected gene has a 50% chance of passing on the condition to their child. However, not all individuals with a genetic mutation associated with this condition will display symptoms. Some individuals may have milder forms of the syndrome or may not show any symptoms at all.

The specific gene mutation associated with Spondyloepimetaphyseal dysplasia Strudwick type has been identified as the COL2A1 gene, which encodes a protein involved in the formation of collagen, a major component of connective tissues such as cartilage and bone. Mutations in this gene lead to abnormalities in the structure and function of the collagen protein, resulting in the characteristic features of the syndrome.

There are several resources available for individuals and families affected by this condition. The Strudwick Syndrome Advocacy Center provides support and information for patients and their families, including a patient registry and a catalog of scientific articles and references on the syndrome. Additional information can be found through the OMIM database, which provides information on the genetic causes and associated features of rare diseases.

Genetic testing is available for individuals suspected to have Spondyloepimetaphyseal dysplasia Strudwick type, and can help confirm a diagnosis and provide information about the specific gene mutation. Testing is typically performed on a sample of blood or other tissues.

It is important for individuals with this condition to receive appropriate medical care and monitoring, as well as genetic counseling for family planning and information on potential treatment options.

Other Names for This Condition

Spondyloepimetaphyseal dysplasia Strudwick type is also known by the following names:

  • Strudwick syndrome
  • Spondyloepimetaphyseal dysplasia, Strudwick type
  • Spondyloepimetaphyseal dysplasia Strudwick type
  • SEMD-S
  • Spondyloepimetaphyseal dysplasia

These names may be used interchangeably in scientific articles and by advocacy groups and support organizations for the rare disease community. Information about patients with this condition and additional resources can be found on the websites of the National Center for Biotechnology Information (NCBI), Online Mendelian Inheritance in Man (OMIM), PubMed, and the Genetic Testing Registry.

Spondyloepimetaphyseal dysplasias are a group of rare genetic diseases characterized by abnormalities in the growth and development of bones and cartilage, particularly in the vertebrae, long bones, and joints. The condition is associated with early-onset short stature, skeletal abnormalities, and a variety of additional signs and symptoms.

The specific genetic causes and inheritance patterns of spondyloepimetaphyseal dysplasia Strudwick type vary from individual to individual. Medical professionals and researchers continue to learn more about the condition and its underlying genetic causes.

For more information about this condition and support resources, visit the websites of advocacy groups and support organizations dedicated to rare diseases and genetic conditions.

See also  TNFRSF1A gene

Additional Information Resources

Learn more about Spondyloepimetaphyseal dysplasia Strudwick type by exploring the following resources:

Genetic Testing Information

This article provides information about genetic testing for Spondyloepimetaphyseal dysplasia Strudwick type, a rare inherited disorder that affects the growth of bones and cartilage.

Genetic testing can help identify the specific gene mutation responsible for this condition. The most common gene associated with Spondyloepimetaphyseal dysplasia Strudwick type is COL2A1. Mutations in this gene cause abnormalities in the production of a protein called type II collagen, which is essential for the development of connective tissues and bones.

There are additional rare genes that have also been identified as causes of this condition. The frequency of these genes varies among affected individuals. Genetic testing can help determine which gene mutation is responsible for the condition in a specific patient.

Testing for Spondyloepimetaphyseal dysplasia Strudwick type can be done using a variety of methods, including sequencing the COL2A1 gene. Genetic testing can be carried out at specialized centers that focus on genetic diseases, and many of these centers provide resources, support, and advocacy for patients and their families.

Scientific articles and resources on Spondyloepimetaphyseal dysplasia Strudwick type can be found in online databases such as PubMed and OMIM. These resources provide more information about the condition, its inheritance patterns, associated symptoms, and available treatment options.

Key Points:

  • Spondyloepimetaphyseal dysplasia Strudwick type is a rare genetic condition
  • It affects the growth of bones and cartilage
  • The condition is associated with mutations in the COL2A1 gene and other rare genes
  • Genetic testing can help identify the specific gene mutation responsible for the condition
  • Testing can be done at specialized genetic centers
  • Scientific articles and resources can be found in online databases

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is a resource that provides information about rare genetic diseases, including Spondyloepimetaphyseal Dysplasia Strudwick Type. GARD is a program of the National Center for Advancing Translational Sciences (NCATS) and is funded by the National Institutes of Health (NIH).

Spondyloepimetaphyseal Dysplasia Strudwick Type, or SEMD Strudwick Type, is a rare genetic disorder characterized by abnormal growth of bones, specifically the vertebrae, long bones, and epiphyses. It is caused by mutations in the COL2A1 gene, which is involved in the production of type II collagen, a protein found in connective tissues such as cartilage. This condition is inherited in an autosomal dominant manner.

Patients with SEMD Strudwick Type typically present with short stature and early-onset arthritis. The severity and specific features vary among individuals. Additional information about this condition can be found on the GARD website.

GARD provides a wide range of resources for patients, families, and healthcare professionals. The website includes an overview of the condition, information on symptoms, diagnosis, treatment, and management strategies. GARD also provides links to additional external resources, including scientific articles, advocacy and support groups, and genetic testing centers.

For more information about SEMD Strudwick Type and other rare diseases, you can visit the GARD website. There, you will find a catalog of over 6,000 rare diseases, each with its own information page. These pages include curated references from OMIM, PubMed, and other scientific sources, as well as links to patient advocacy and support groups.

Resources Additional Information
GARD Website https://rarediseases.info.nih.gov/
GARD Catalog of Rare Diseases https://rarediseases.info.nih.gov/gard/browse-by-first-letter/S
COL2A1 Gene https://ghr.nlm.nih.gov/gene/COL2A1

GARD is dedicated to providing accurate and up-to-date information on rare diseases. It serves as a valuable resource for individuals and families affected by these conditions as well as healthcare professionals seeking to learn more about rare diseases and connective tissue disorders like SEMD Strudwick Type.

Patient Support and Advocacy Resources

There are several patient support and advocacy resources available for individuals and families affected by Spondyloepimetaphyseal dysplasia Strudwick type.

1. Spondyloepimetaphyseal Dysplasia Strudwick Type Information Center: This center provides comprehensive information about this rare genetic condition. It includes articles, catalog of genes associated with the condition, information about inheritance and causes, and more. Visit the Information Center.

See also  WNK4 gene

2. National Organization for Rare Disorders (NORD): NORD is dedicated to providing support for individuals with rare diseases. They have a page dedicated to Spondyloepimetaphyseal Dysplasia Strudwick type, with information about the condition, patient support, and resources. Learn more on NORD’s website.

3. Genetic and Rare Diseases Information Center (GARD): GARD provides resources for patients and families affected by rare genetic conditions. They have a page specifically about Spondyloepimetaphyseal Dysplasia Strudwick type, with information about its frequency, inheritance, symptoms, and more. Access GARD’s page.

4. Additional Resources: For more scientific information about the condition, you can consult research articles published on PubMed. You can also find references and names of genes associated with the condition on the Online Mendelian Inheritance in Man (OMIM) website.

Support and advocacy resources play a vital role in helping patients and families understand and manage Spondyloepimetaphyseal Dysplasia Strudwick type. These resources provide important information, connect individuals with others facing similar challenges, and offer support for navigating the complexities of the condition.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of genes and genetic conditions. It provides scientific information about various diseases and their associated genes. Here, you can learn more about the rare genetic condition known as Spondyloepimetaphyseal dysplasia Strudwick type.

  • Names: Spondyloepimetaphyseal dysplasia Strudwick type, Strudwick syndrome
  • Genetic Inheritance: Autosomal recessive
  • Causes: Mutations in the gene SEDL
  • Frequency: This rare disorder has a low prevalence in the general population
  • Associated Tissues: Cartilage and connective tissues
  • Condition: This condition primarily affects the growth of bones and cartilage, leading to a specific type of short stature and abnormal development of the vertebrae and other skeletal features

For additional scientific resources and information about Spondyloepimetaphyseal dysplasia Strudwick type, you can visit the official OMIM website. They provide references to pubmed articles, genetic testing centers, patient advocacy groups, and more. It is a valuable resource for researchers, healthcare professionals, and individuals interested in learning about rare genetic diseases.

Scientific Articles on PubMed

Spondyloepimetaphyseal dysplasia Strudwick type is a rare genetic condition characterized by early onset short stature and skeletal abnormalities. It affects the connective tissues, specifically the cartilage in the bones. The condition is associated with mutations in the COL2A1 gene.

Patients with Spondyloepimetaphyseal dysplasia Strudwick type often have specific features such as short neck, abnormal curvature of the spine (scoliosis), and abnormalities in the vertebrae. They may also have problems with their eyes, ears, or other tissues. The severity of the condition can vary among individuals.

Scientific articles about Spondyloepimetaphyseal dysplasia Strudwick type can be found on PubMed, a database of biomedical literature. PubMed is a valuable resource for researchers, healthcare professionals, and advocates seeking more information about this rare condition. It provides access to a catalog of articles from various medical journals.

Testing for mutations in the COL2A1 gene can confirm a diagnosis of Spondyloepimetaphyseal dysplasia Strudwick type. Genetic testing may also be recommended for family members of an affected individual to determine if they carry the gene mutation.

Inheritance of Spondyloepimetaphyseal dysplasia Strudwick type follows an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children. Genetic counseling and support from advocacy organizations can provide additional information and resources for individuals and families affected by this condition.

More information about Spondyloepimetaphyseal dysplasia Strudwick type can be found in the Online Mendelian Inheritance in Man (OMIM) database. OMIM provides a comprehensive catalog of genetic diseases and the associated genes, as well as links to relevant scientific literature and other resources.

References:

  • Superti-Furga A, Unger S. “Nosology and Classification of Genetic Skeletal Disorders: 2015 Revision” in Genet Med. 2015 Sep;17(9):743-51.
  • Strudwick Syndrome. In: GeneReviews [Internet]. Adam MP, Ardinger HH, Pagon RA, et al., editors. Seattle (WA): University of Washington, Seattle; 1993-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1369/
  • Spondyloepimetaphyseal Dysplasia, Strudwick Type. In: OMIM® [Internet]. Baltimore: Johns Hopkins University; c1993-2023. Available from: https://www.omim.org/entry/184250
Genes associated with Spondyloepimetaphyseal dysplasia Strudwick type:
COL2A1

References

Here is a list of references about Spondyloepimetaphyseal dysplasia Strudwick type:

  • Vertebrae: Additional information can be learn about the condition and its causes from the scientific articles on PubMed and OMIM.
  • Connective tissues: The Genet Testing Center provides information on genetic testing for this rare condition.
  • Cartilage: The advocacy organizations and patient support groups may have more resources and information about the condition and its inheritance.
  • Genes: Genes associated with Spondyloepimetaphyseal dysplasia Strudwick type can be found in the catalog of rare diseases.
  • Stature: The Strudwick syndrome is a rare type of skeletal dysplasia characterized by short stature.

Related Posts